(-0.07%) 5 465.54 points
(0.08%) 39 143 points
(0.17%) 17 747 points
(0.07%) $80.89
(-5.04%) $2.62
(-0.80%) $2 312.20
(-0.06%) $28.85
(3.28%) $1 018.80
(0.35%) $0.936
(0.74%) $10.68
(0.50%) $0.792
(-0.28%) $87.25
22.63% $ 0.478
Live Chart Being Loaded With Signals
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases...
Stats | |
---|---|
Volumen de hoy | 7 588 |
Volumen promedio | 62 408 |
Capitalización de mercado | 35.36M |
EPS | $-0.0462 ( Q3 | 2023-02-14 ) |
Last Dividend | $0.435 ( 2024-02-08 ) |
Next Dividend | $0 ( N/A ) |
P/E |
-1.226 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0220 (4.60%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-02-08 | Meswani Parag V | Buy | 153 700 | Restricted Stock Units |
2022-02-08 | Nassif David W. | Buy | 546 500 | Restricted Stock Units |
2022-01-28 | Meswani Parag V | Sell | 0 | Common Stock |
2022-01-28 | Meswani Parag V | Sell | 15 625 | Stock Option (Right to Buy) |
2022-01-28 | Meswani Parag V | Sell | 12 500 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
0.00 |
Last 89 transactions |
Buy: 137 127 498 | Sell: 478 048 |
Volumen Correlación
Sio Gene Therapies Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sio Gene Therapies Inc. Correlación - Moneda/Commodity
Sio Gene Therapies Inc. Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $0 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $0 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-0.980 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.620 |
Financial Reports:
No articles found.
Sio Gene Therapies Inc. Dividends
(Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.435 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.435 | 2024-02-08 |
Last Dividend | $0.435 | 2024-02-08 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.435 | -- |
Avg. Dividend % Per Year | 113.00% | -- |
Score | 4.01 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2024 | $0.435 | 113.00% |
Unable to generate commentary due to missing data.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
08 Feb 2024 | $0.435 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Diamond | 2024-09-16 | Monthly | 14 | 15.03% | 9.60 |
DMLP | Dividend Diamond | 2024-04-26 | Quarterly | 22 | 10.71% | 9.35 |
OXSQ | Dividend Diamond | 2024-09-16 | Monthly | 21 | 12.73% | 9.02 |
ARLP | Dividend Royal | 2024-05-07 | Quarterly | 26 | 9.67% | 8.87 |
PNNT | Dividend Royal | 2024-06-14 | Monthly | 18 | 9.49% | 8.82 |
MFIC | Dividend Royal | 2024-06-11 | Quarterly | 21 | 10.89% | 8.79 |
SPOK | Dividend Royal | 2024-05-23 | Quarterly | 20 | 8.73% | 8.72 |
PSEC | Dividend Royal | 2024-06-25 | Monthly | 21 | 9.03% | 8.65 |
SBLK | Dividend Royal | 2024-06-06 | Quarterly | 17 | 13.10% | 8.63 |
GBDC | Dividend Royal | 2024-11-29 | Bi-Monthly | 15 | 8.53% | 8.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0 | 1.500 | 0 | 0 | [0 - 0.5] |
returnOnAssetsTTM | -0.136 | 1.200 | -4.54 | -5.45 | [0 - 0.3] |
returnOnEquityTTM | -0.137 | 1.500 | -2.63 | -3.95 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 21.97 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 21.60 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 21.43 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 11.69 | 1.000 | 6.78 | 6.78 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.135 | 2.00 | -0.0451 | -0.0902 | [0 - 30] |
freeCashFlowPerShareTTM | -0.139 | 2.00 | -0.0697 | -0.139 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0 | 1.000 | -3.33 | -3.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0 | 1.000 | -2.00 | -2.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 1.005 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -5.49 | 1.000 | -0.656 | 0 | [1 - 100] |
returnOnEquityTTM | -0.137 | 2.50 | -1.692 | -3.95 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.139 | 2.00 | -0.0464 | -0.139 | [0 - 30] |
dividendYielPercentageTTM | 91.00 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.135 | 2.00 | -0.0451 | -0.0902 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0697 | 1.500 | -3.80 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0 | 1.000 | -2.50 | 0 | [0.1 - 0.5] |
Total Score | -0.327 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Sio Gene Therapies Inc.
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico